Climber Mortality on Mount Aconcagua, 2013-2024.

IntroductionMount Aconcagua (6961 m) is the highest peak in the Americas, and thousands of climbers attempt to climb it annually. This study aimed to characterize recent climber mortality on Aconcagua to aid in future safety efforts.MethodsClimber fatalities from Aconcagua for the 10 most recent climbing seasons (2013-2024) were retrospectively reviewed.

Medical Evacuations of Climbers on Mount Aconcagua, 2022-2024.

IntroductionMount Aconcagua (6961 m) is the highest peak in the Western Hemisphere and attempted by over 3000 climbers annually. Aconcagua Provincial Park (APP) and the APP medical service oversee all rescues and medical care. This study aims to describe patients and conditions requiring rescue medical evacuation on Aconcagua.

Characteristics of Climbers with High Altitude Pulmonary Edema on Mount Aconcagua.

Introduction—: Mount Aconcagua (6961 m) in Argentina is the highest peak in the Americas, and more than 3000 climbers attempt to summit annually. High altitude pulmonary edema (HAPE) is a leading cause of mortality and evacuation on Aconcagua.

Objective—: This study sought to describe the characteristics of climbers who developed HAPE on Aconcagua to aid in future prevention efforts.

Acute Coronary Syndrome at Altitude: Diagnostic Dilemma on Aconcagua Using Point-of-Care Ultrasound.

At the Plaza de Mulas medical tent, located at 4300 m (14,100 ft) along the Normal Route to the 6960 m (22,837 ft) summit of Aconcagua in Argentina, a Korean male in his 50s with no known medical conditions presented with lightheadedness and shortness of breath. He had taken sildenafil and acetazolamide that morning without improvement. Vital signs on arrival were notable for oxygen saturations in the high 60s with basilar crackles on lung auscultation, concerning for high altitude pulmonary edema.